Comparison of the effects of captopril, tamoxifen and L-carnitine on renal structure and fibrosis after total unilateral ureteral obstruction in the rat

References

• Klahr S. New insights into the consequences and mechanisms of renal impairment in obstructive nephropathy. Am J Kidney Dis 1991; 18: 689–99
   PubMed Web of Science ®Google Scholar
• Klahr S. Obstructive uropathy. Renal and electrolyte disorders6th ed, RW Schrier. Lippincott Williams and Wilkins, Philadelphia, PA 2003; 520
   Google Scholar
• Nagle RB, Bulger RE. Unilateral obstructive nephropathy in the rabbit. II. Late morphologic changes. Lab Invest 1978; 38: 270–8
   PubMed Web of Science ®Google Scholar
• Hochberg D, Johnson CW, Chen J, Cohen D, Stern J, Vaughan ED, Jr, et al. Interstitial fibrosis of unilateral ureteral obstruction is exacerbated in kidneys of mice lacking the gene for inducible nitric oxide synthase. Lab Invest 2000; 80: 1721–8
   PubMed Web of Science ®Google Scholar
• Kaneto H, Morrissey J, Klahr S. Increased expression of TGF-beta 1 mRNA in the obstructed kidney of rats with unilateral ureteral ligation. Kidney Int 1993; 44: 313–21
   PubMed Web of Science ®Google Scholar
• Wright EJ, McCaffrey TA, Robertson AP, Vaughan ED, Jr, Felsen D. Chronic unilateral ureteral obstruction is associated with interstitial fibrosis and tubular expression of transforming growth factor-beta. Lab Invest 1996; 74: 528–37
   PubMed Web of Science ®Google Scholar
• Furness PD 3rd, Maizels M, Han SW, Cohn RA, Cheng EY. Elevated bladder urine concentration of transforming growth factor-beta1 correlates with upper urinary tract obstruction in children. J Urol 1999; 162: 1033–6
   PubMed Web of Science ®Google Scholar
• Kaneto H, Morrissey J, McCracken R, Reyes A, Klahr S. Enalapril reduces collagen type IV synthesis and expansion of the interstitium in the obstructed rat kidney. Kidney Int 1994; 45: 1637–47
   PubMed Web of Science ®Google Scholar
• Dedeoglu F, Rose CD, Athreya BH, Conard K, Grissom L, Magnusson M. Successful treatment of retroperitoneal fibrosis with tamoxifen in a child. J Rheumatol 2001; 28: 1693–5
   PubMed Web of Science ®Google Scholar
• De M, Jaap A, Dempster J. Tamoxifen therapy in steroid-resistant Riedels disease. Scott Med J 2002; 47: 12–3
   PubMed Web of Science ®Google Scholar
• Ralph DJ, Brooks MD, Bottazzo GF, Pryor JP. The treatment of Peyronie's disease with tamoxifen. Br J Urol 1992; 70: 648–51
   PubMedGoogle Scholar
• Teloken C, Rhoden EL, Grazziotin TM, Ros CT, Sogari PR, Souto CA. Tamoxifen versus placebo in the treatment of Peyronie's disease. J Urol 1999; 162: 2003–5
   PubMed Web of Science ®Google Scholar
• Mikulec AA, Hanasono MM, Lum J, Kadleck JM, Kita M, Koch RJ. Effect of tamoxifen on transforming growth factor beta1 production by keloid and fetal fibroblasts. Arch Facial Plast Surg 2001; 3: 111–4
   PubMedGoogle Scholar
• Panko WB, Beamon CR, Middleton GW, Gillenwater JY. Effect of obstruction of renal metabolism. Renal tissue metabolite concentration after alpha-ketoglutarate infusion. Invest Urol 1978; 15: 331–9
   PubMedGoogle Scholar
• Stecker JF, Jr, Vaughan ED, Jr, Gillenwater JY. Alteration in renal metabolism occurring in ureteral obstruction in vivo. Surg Gynecol Obstet 1971; 133: 846–8
   PubMedGoogle Scholar
• Nito H, Descoeudres C, Kurokawa K, Massry SG. Effect of unilateral obstruction on renal cell metabolism and function. J Lab Clin Med 1978; 91: 60–71
   PubMed Web of Science ®Google Scholar
• Calvani M, Reda E, Arrigoni-Martelli E. Regulation by carnitine of myocardial fatty acid and carbohydrate metabolism under normal and pathological conditions. Basic Res Cardiol 2000; 95: 75–83
   PubMed Web of Science ®Google Scholar
• Uhal BD, Gidea C, Bargout R, Bifero A, Ibarra-Sunga O, Papp M, et al. Captopril inhibits apoptosis in human lung epithelial cells: a potential antifibrotic mechanism. Am J Physiol 1998; 275: L1013–7
   PubMedGoogle Scholar
• Jonsson JR, Clouston AD, Ando Y, Kelemen LI, Horn MJ, Adamson MD, et al. Angiotensin-converting enzyme inhibition attenuates the progression of rat hepatic fibrosis. Gastroenterology 2001; 121: 148–55
   PubMed Web of Science ®Google Scholar
• Sener G, Paskaloglu K, Satiroglu H, Alican I, Kacmaz A, Sakarcan A, et al. L-carnitine ameliorates oxidative damage due to chronic renal failure in rats. J Cardiovasc Pharmacol 2004; 43: 698–705
   PubMed Web of Science ®Google Scholar
• Czerny B, Teister M, Juzyszyn Z, Modrzejewski A, Pawlik A. The effect of tamoxifen and fluoride on bone mineral density, biomechanical properties and blood lipids in ovariectomized rats. Basic Clin Pharmacol Toxicol 2004; 95: 162–5
   PubMed Web of Science ®Google Scholar
• Mouton PR, editor. Principles and practices of unbiased stereology. An introduction for bioscientists. Baltimore, MD: The Johns Hopkins University Press; 2002. p. 88–112.
   Google Scholar
• Nyengaard JR. Stereologic methods and their application in kidney research. J Am Soc Nephrol 1999; 10: 1100–23
   PubMed Web of Science ®Google Scholar
• Gundersen HJ, Bendtsen TF, Korbo L, Marcussen N, Moller A, Nielsen KL, et al. Some new, simple and efficient stereological methods and their use in pathological research and diagnosis. APMIS 1988; 96: 379–94
   PubMed Web of Science ®Google Scholar
• Sharma AK, Mauer SM, Kim Y, Michael AF. Interstitial fibrosis in obstructive nephropathy. Kidney Int 1993; 44: 774–88
   PubMed Web of Science ®Google Scholar
• Klahr S, Ishidoya S, Morrissey J. Role of angiotensin II in the tubulointerstitial fibrosis of obstructive nephropathy. Am J Kidney Dis 1995; 26: 141–6
   PubMed Web of Science ®Google Scholar
• Mannisto TK, Karvonen KE, Kerola TV, Ryhanen LJ. Inhibitory effect of the angiotensin converting enzyme inhibitors captopril and enalapril on the conversion of procollagen to collagen. J Hypertens 2001; 19: 1835–9
   PubMed Web of Science ®Google Scholar
• Yu L, Border WA, Anderson I, McCourt M, Huang Y, Noble NA. Combining TGF-beta inhibition and angiotensin II blockade results in enhanced antifibrotic effect. Kidney Int 2004; 66: 1774–84
   PubMed Web of Science ®Google Scholar
• McDougal WS. Pharmacologic preservation of renal mass and function in obstructive uropathy. J Urol 1982; 128: 418–21
   PubMed Web of Science ®Google Scholar
• Puce R, Porcaro AB, Curti P, Girelli D, Pantalena M, Malossini G, et al. Treatment of retroperitoneal fibrosis with tamoxifen: case report and review of literature. Arch Esp Urol 2000; 53: 184–90
   PubMedGoogle Scholar
• Owens LV, Cance WG, Huth JF. Retroperitoneal fibrosis treated with tamoxifen. Am Surg 1995; 61: 842–4
   PubMed Web of Science ®Google Scholar
• Chambers JC, McGovern K. Tamoxifen for retroperitoneal fibrosis. Palliat Med 2005; 19: 163–4
   PubMed Web of Science ®Google Scholar